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We want to discuss how recent dramatic progress in whole-
genome association analysis (WGA) applied to human case-
control studies will affect complex trait analysis in the
mouse. At ﬁrst sight it might now seem that one can identify
the genetic determinants of human complex disease
directly. However, the picture is less straightforward, for
although a signiﬁcant number of genes have been identiﬁed
and replicated across different humanWGA studies, in most
diseases the genetic variation segregating at these genes
explains only a small fraction of cases that should be
accounted for by genetic causes. The question remains
whether the missing genetic signal is from common variants
in other genes but with very small phenotypic effect, or is
caused by rare variants in the same genes, or a combination
of both. In either case, to continue making progress directly
with the human WGA methodology it will be necessary to
increase sample sizes signiﬁcantly (Zeggini et al. 2008).
Where does this leave mouse complex genetics? Of
course, as the readers of Mammalian Genome will appre-
ciate, working with mice does have certain advantages in
that it is possible to design and control experiments and
take detailed measurements in a way that is impossible
with humans. Nevertheless, the mouse complex genetics
community must address three key issues in order to con-
tribute to our understanding of human biology and disease.
The ﬁrst of these is mapping resolution. We need to
establish suitable mouse populations in which high-reso-
lution mapping is the norm. The small extent of linkage
disequilibrium (LD) in most human populations means that
a positive signal in a human WGA is localized to a few tens
of kilobases, usually the span a single gene. Assuming that
the functional genetic variant acts on the nearest gene
(which is not always the case), then human WGA delivers
single-gene resolution. In contrast, a detected QTL in an F2
intercross between two inbred laboratory mouse strains that
explains 5% of the phenotypic variance will be mapped
into a 95% conﬁdence interval of approximately 30 Mb,
containing approximately 300 genes. In some cases, com-
bining information from multiple F2 crosses with the
haplotype map of the mouse genome can reﬁne QTL
localization (Hitzemann et al. 2002; Li et al. 2005). Sev-
eral other strategies have been proposed to solve this
problem, by using populations of mice with more recom-
binants, and consequently steeper LD decay proﬁles.
Heterogeneous stocks (HS) are descended from eight
known inbred strain of mice that are outcrossed using a
rotational breeding scheme for many generations until the
genomes are relatively ﬁne-grained mosaics of the founder
haplotypes; mapping resolution of 2–3Mb is obtainable
(Mott et al. 2000; Talbot et al. 1999; Valdar et al.2006).
However, despite being much more accurate than an F2
cross, this is still too crude for single-gene mapping for
which we require mapping resolution of about 100 kb.
Commercial mouse breeders maintain very large
genetically heterogeneous outbred populations, some of
which are suitable for complex trait analysis. As proof of
principle, Yalcin et al. (2004) showed how one such pop-
ulation, MF1, could be used to ﬁne-map a QTL for
behavior down to the gene Rgs2. Our group is now in the
process of evaluating the genetic variability and LD proﬁle
of several commercially available outbred populations.
Preliminary data suggest that there are some populations
that have suitable properties but that others are not useful,
having been recently rederived from a small number of
animals and therefore containing extensive LD. There is
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gests they have an LD structure similar to that of humans
(Laurie et al. 2007).
The disadvantage of working with outbreds is that each
animal is unique so that it is impossible to perform repeat
experiments on the same genetic background, which may
be necessary; for example, in a study to measure gene
expression changes during development. Furthermore, the
cost of high-density genotyping required limits the size of
experiments. In contrast, inbred strains of mice permit
these types of studies, need only be genotyped once, and
there is a synergy in accumulating data from different
experiments on standardized genetic backgrounds. There
has been considerable debate over the direct use of the
standard laboratory inbred strains for WGA. The main
point of contention is that the number of independent
inbred strains available is limited (for example, the mouse
phenome database http://www.phenome.jax.org/pub-cgi/
phenome/mpdcgi uses less than 40 priority strains, and
even these strains share haplotypes to a considerable
degree). Although the method may work for major QTLs
explaining over 50% of the phenotypic variance, results are
mixed for complex traits (Payseur and Place 2007) where
QTLs of small effect are lost among false-positive signals
in a genome scan. On the other hand, the sharp LD decay
proﬁle of the inbred strains is very attractive, so that if one
can be sure that a QTL is segregating in a region (for
example, from an F2 cross), then an analysis of inbred
strains across the region may identify the gene in some
cases. In addition, there is a considerable saving in geno-
typing costs.
This discussion suggests there is a strong case for
designing and constructing a large population of inbred
lines that contains a high density of recombinants and
where the lines are independent, in the sense that they do
not share any recombination events. This was the motiva-
tion behind the Collaborative Cross (CC) (Churchill et al.
2004; Threadgill et al. 2002). Currently, over 400 CC
recombinant inbred lines are being bred at Oak Ridge
National Laboratary, USA, and Tel Aviv University, Israel,
in a collaboration funded by the U.S. Department of
Energy (DOE), The Ellison Foundation, National Institutes
of Health (NIH), and The Wellcome Trust. The lines are
descended from eight genetically diverse founder strains
(including three wild-derived strains) and are currently
between generation 6 and 10 of inbreeding. They will be
fully inbred in about 4 years but are already sufﬁciently
advanced that a pilot project is planned to assess their use
for QTL mapping. The CC is almost ideal, except that the
expected QTL mapping resolution is about 1 Mb (Valdar
et al. 2005)—not quite single gene.
The second issue is that the haplotype structure of the
classical laboratory strains of mice is not ideal for complex
trait analysis. To make best use of the mouse, we need
complete genome sequences of the common laboratory
strains. Already we know from partial resequencing of 16
strains that the so-called classical strains share only a
fraction of the genetic variation segregating in wild-derived
strains (Frazer et al. 2007; Yang et al. 2007) so there
should be fewer QTLs in a study solely using classical
strains. Moreover, their genomes are not independent; the
pattern of haplotype sharing is not random across the
genome, causing the problem of false-positive QTLs allu-
ded to above. By contrast, the haplotype structure of the
CC is necessarily random, very rare variants should not
exist, and the founding strains contain more genetic vari-
ation than is present in some human populations (Roberts
et al. 2007). We do not yet know much about the haplotype
structure or origins of commercial outbreds.
The third issue is how we should relate discoveries made
in the mouse to human disease. It should be reiterated that
many studies in mice are not feasible in humans, such as
the elucidation of gene networks from most tissues and
developmental stages. As it is extremely unlikely that
identical causative polymorphisms will be segregating in
both species, we should not necessarily expect the same
genes to be identiﬁed in WGA, although there are exam-
ples where this is the case, such as cancer modiﬁers
common to mice and humans (Ruivenkamp et al. 2002).
Nevertheless, we should expect the same pathways to be
implicated (Emilsson et al. 2008). However, at present the
functional annotation of both species is incomplete.
Therefore, alongside the development of suitable mapping
populations, we need comprehensive annotation of the
gene networks in the mouse, and how they vary during
development, between tissues and between genetic back-
grounds. There is not space here to say more except that it
will require a concerted international effort, integrating and
extending existing online resources.
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